Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Sanofi
|
| gptkbp:acquisitionYear |
2021
|
| gptkbp:developedBy |
immune-oncology therapeutics
prodrugs |
| gptkbp:focusesOn |
oncology
protein therapeutics |
| gptkbp:foundedYear |
2006
|
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Amunix Pharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:technology |
XTEN technology
pro-XTEN |
| gptkbp:website |
https://www.amunix.com/
|
| gptkbp:bfsParent |
gptkb:Frazier_Healthcare_Ventures
gptkb:Fine_Structure_Ventures gptkb:The_Column_Group gptkb:Versant_Ventures |
| gptkbp:bfsLayer |
7
|